Evidence map›Paper›PMID 22607883›Full record

ArticleBioorganic & medicinal chemistry2012

Synthesis and antiviral activity of certain second generation methylenecyclopropane nucleosides.

John D Williams, Atiyya R Khan, Emma A Harden, Caroll B Hartline, Geraldine M Jefferson, Kathy A Keith, Mark N Prichard, Jiri Zemlicka, Norton P Peet, Terry L Bowlin

Abstract read
In one paragraph

Article in Bioorganic & medicinal chemistry, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

John D WilliamsMicrobiotix, Inc., One Innovation Drive, Worcester, MA 01605, USA. jwilliams@microbiotix.com
Atiyya R Khan
Emma A Harden
Caroll B Hartline
Geraldine M Jefferson
Kathy A Keith
Mark N Prichard
Jiri Zemlicka
Norton P Peet
Terry L Bowlin

Funding

Novel Methylenecyclopropane Analogues as Anti-Human Herpesvirus 6 and 8 AgentsR44AI082799 · NIAID · MICROBIOTIX, INC · PI BOWLIN, TERRY L. · 2012 to 2014
$3.0M
Novel Methylenecyclopropane Analogues as Anti-Human Herpesvirus 6 and 8 AgentsR43AI082799 · NIAID · MICROBIOTIX, INC · PI BOWLIN, TERRY L. · 2009 to 2010
$634k
NIAID NIH HHS 1R43AI082799NIAID NIH HHS HHSN272201100001CNIAID NIH HHS HHSN272201100001GNIAID NIH HHS HHSN272201100010CNIAID NIH HHS N01 AI030049NIAID NIH HHS N01-AI-30049NIAID NIH HHS R43 AI082799NIAID NIH HHS R44 AI082799PHS HHS HHSN2722011000010C
6 · The paper itself

Abstract

A second-generation series of substituted methylenecyclopropane nucleosides (MCPNs) has been synthesized and evaluated for antiviral activity against a panel of human herpesviruses, and for cytotoxicity. Although alkylated 2,6-diaminopurine analogs showed little antiviral activity, the compounds containing ether and thioether substituents at the 6-position of the purine did demonstrate potent and selective antiviral activity against several different human herpesviruses. In the 6-alkoxy series, antiviral activity depended on the length of the ether carbon chain, with the optimum chain length being about four carbon units long. For the corresponding thioethers, compounds containing secondary thioethers were more potent than those with primary thioethers.

Indexed as

Antiviral AgentsCell LineCyclopropanesDose-Response Relationship, DrugFibroblastsHerpesviridaeHumansMicrobial Sensitivity TestsMolecular ConformationNucleosidesStructure-Activity RelationshipAntiviral AgentsCyclopropanesmethylenecyclopropaneNucleosides

Identifiers

PMID22607883
PMCPMC3509806

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.